4.195USD-4.55%Mkt Cap: 1.51B USDP/E: —Last update: 2026-06-01
Precigen, Inc.,a discovery and clinical-stage biopharmaceutical company, develops gene and cell therapies using precision technology to target diseases in areas of immuno-oncology, autoimmune disorders, and infectious di…
Industry Peers
Biotechnology111.39BUSDP/E 26.0
100.62BDKKP/E 19.4
62.97BUSDP/E 14.7
48.39BEURP/E 31.7
44.65BEURP/E 37.2
40.10BUSDP/E 75.3
35.22BUSD—
32.91BSEKP/E 48.6
Indicators:|
Key Statistics
Company
Market Cap1.51B USD
Enterprise Value1.59B USD
Revenue (TTM)31.59M USD
Gross Profit4.86M USD
Net Income (TTM)-250.64M USD
Revenue/Share0.0960 USD
Last Price4.195 USD
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees160
CountryUS
SectorHealthcare
IndustryBiotechnology
ISINUS74017N1054
Valuation
P/E (Trailing)—
P/E (Forward)-19.73
PEG—
EV/EBITDA-18.41
EV/Revenue50.30
P/S48.97
P/B76.14
EPS (TTM)-1.21
EPS (Forward)-0.22
52W Range
1.28070% of range5.470
52W High5.470 USD
52W Low1.280 USD
Profitability
Gross Margin50.20%
Oper. Margin-25.78%
EBITDA Margin-273.24%
Profit Margin-2588.21%
ROE-1198.61%
ROA-161.18%
Growth
Revenue Growth1633.90%
Earnings Growth—
Cash Flow & Leverage
Operating CF-87.83M USD
CapEx (TTM)2.00M USD
FCF Margin-285.21%
FCF Yield-5.98%
Net Debt42.00M USD
Net Debt/EBITDA-0.49
Balance Sheet
Debt/Equity4.70
Current Ratio4.82
Quick Ratio3.93
Book Value/Sh0.0570 USD
Cash/Share0.1580 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating2.0 (Buy)
Target (Mean)12.45 USD
Target Range11.00 USD – 13.90 USD
# Analysts2
Ownership
Shares Out.356.51M
Float189.75M
Insiders13.78%
Institutions71.04%
Short Interest
Short Ratio12.5d
Short % Float20.59%
Short % Out.11.18%
Shares Short39.87M
Short (prev mo.)39.79M
Technical
SMA 504.001 (+4.8%)
SMA 2003.972 (+5.6%)
Beta1.07
S&P 52W Chg27.70%
Avg Vol (30d)3.31M
Avg Vol (10d)4.61M
Technical Indicators
RSI (14)55.5
MACD0.0828
MACD Signal0.0768
MACD Hist.+0.0060
BB Upper4.553 USD
BB Middle4.257 USD
BB Lower3.961 USD
BB Width13.93%
ATR (14)0.2615 USD
Vol Ratio (20d)0.90x